United States - English - NLM (National Library of Medicine)

bimeda, inc. - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - praziquantel 56.8 mg in 1 ml - praziquantel injection cestocide is indicated for the removal of the following canine and/or feline cestodes. dogs: dipylidium caninum, taenia pisiformis, echinococcus granulosus and for the removal and control of echinococcus multilocularis. cats: taenia taeniaeformis and dipylidium caninum. there are no known contraindications to the use of praziquantel.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetafarm pty.ltd. - praziquantel; oxfendazole - oral solution/suspension - praziquantel anthelmintic active 20.0 g/l; oxfendazole triazole active 20.0 g/l - parasiticides - domestic birds | aviary bird | budgerigar | cage birds | canary | finch | parrot | pigeon - caecal worm - heterakis gallinae | hookworm - acuaria spp. | roundworm - ascaris spp. | tapeworm - choanotaenia spp. | tapeworm - raillietina spp. | threadworm - capillaria spp. | hair worm | heterakis gallinarum

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - praziquantel tablets are indicated in patients aged 1 year and older for the treatment of the following infections: - schistosomiasis due to all species of schistosoma (for example, schistosoma mekongi, schistosoma japonicum, schistosoma mansoni and schistosoma hematobium ), and - clonorchiasis and opisthorchiasis due to the liver flukes, clonorchis sinensis/opisthorchis viverrini (approval of this indication was based on studies in which the two species were not differentiated) praziquantel is contraindicated in: - patients who previously have shown hypersensitivity to praziquantel or any of the excipients in praziquantel tablets. - patients with ocular cysticercosis; since parasite destruction within the eye that occurs because of hypersensitivity reaction to the dead parasite after treatment may cause irreversible lesions, ocular cysticercosis must not be treated with praziquantel. - patients taking strong cytochrome p450 (cyp450) inducers, such as rifampin, [see warnings and  precautions (5.6)  and d

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - praziquantel; fenbendazole - tablet - 50, 500 mg/tablet - praziquantel, combinations - cats, dogs - anthelmintic

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - praziquantel; fenbendazole - tablet - 50/500 mg/tablet - praziquantel, combinations - cats, dogs - anthelmintic

United States - English - NLM (National Library of Medicine)

attix pharmaceuticals - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - praziquantel 1 kg in 1 kg

Kenya - English - Pharmacy and Poisons Board

biodeal laboratories ltd p.o. box 32040 nairoki kenya - praziquantel - tablet - praziquantel 600mg - antitrematodal anthelmintic agents:

Kenya - English - Pharmacy and Poisons Board

umedica laboratories pvt ltd plot no. 221 lind phase g.i.d.c. vapi - 396195 - praziquantel - tablet - praziquantel 600mg - antitrematodal anthelmintic agents:

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - moxidectin; praziquantel; oxfendazole - oral paste - moxidectin anthelmintic active 8.0 mg/g; praziquantel anthelmintic active 50.0 mg/g; oxfendazole triazole active 200.0 mg/g - parasiticides

United States - English - NLM (National Library of Medicine)

felix pharmaceuticals private limited - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - praziquantel tablets 34 mg canine cestocide are indicated for the removal of the following canine cestodes: dipylidium caninum, taenia pisiformis, echinococcus granulosus and for the removal and control of echinococcus multilocularis.   there are no known contraindications to the use of praziquantel in dogs.